Oxybutynin Extended Release and Tolterodine Immediate Release: A Health Economic Comparison

Author： Getsios D.  

Publisher： Adis International

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.24, Iss.2, 2004-01, pp. : 81-88

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost Effectiveness of Controlled-Release Oxybutynin Compared with Immediate-Release Oxybutynin and Tolterodine in the Treatment of Overactive Bladder in the UK, France and Austria

By Guest J.F.   Abegunde D.   Ruiz F.J.  

Clinical Drug Investigation, Vol. 24, Iss. 6, 2004-01 ,pp. : 305-321

Adis International

Access to resources Recommend Favorite

Effect of Antacid on the Pharmacokinetics of Extended-Release Formulations of Tolterodine and Oxybutynin

By Gayatri Sathyan  

Clinical Pharmacokinetics, Vol. 43, Iss. 14, 2004-01 ,pp. : 1059-1068

Adis International

Access to resources Recommend Favorite

Multiple Dose Pharmacokinetics of a New Once Daily Extended Release Tolterodine Formulation Versus Immediate Release Tolterodine

By Olsson B.  

Clinical Pharmacokinetics, Vol. 40, Iss. 3, 2001-01 ,pp. : 227-235

Adis International

Access to resources Recommend Favorite

Extended-Release Oxybutynin

By Comer A.M.   Goa K.L.  

Drugs & Aging, Vol. 16, Iss. 2, 2000-02 ,pp. : 149-155

Adis International

Access to resources Recommend Favorite

Cost-Effectiveness Analysis of Extended-Release Formulations of Oxybutynin and Tolterodine for the Management of Urge Incontinence

By Hughes Dyfrig A.  

PharmacoEconomics, Vol. 22, Iss. 16, 2004-01 ,pp. : 1047-1059

Adis International

Access to resources Recommend Favorite